Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Detection of Platelet Dysfunction Due to P2Y12 Antiplatelet Drugs

NCT03111420 is registered in ClinicalTrials.gov with Aggredyne, Inc. as lead sponsor.

NCT NCT03111420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03111420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study of the AggreGuide A-100 Adenosine Diphosphate (ADP) Assay to Evaluate the Detection of Platelet Dysfunction Due to P2Y12 Antiplatelet Drugs
Lead sponsor
Aggredyne, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 9, 2017
Completion date
June 30, 2018
Enrollment
280 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

platelet dysfunction due to drugs, risk factor, cardiovascular